Skip to content
10-Q

Quarterly Report

ANTARES PHARMA, INC.

0001016169-21-000045

← back to feed
Filed
Nov 4, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 1, 2021 170.04M sh
Shares Diluted Q3 2021 · Sep 30, 2021 175.13M sh
Shares Diluted Q3 2021 · Sep 30, 2021 174.94M sh
Shares Diluted Q3 2021 · Sep 30, 2020 169.66M sh
Shares Diluted Q3 2021 · Sep 30, 2020 169.76M sh
Capex Q3 2021 · Sep 30, 2021 $4.96M
Capex Q3 2021 · Sep 30, 2020 $7.89M
Operating Cash Flow Q3 2021 · Sep 30, 2021 $27.13M
Operating Cash Flow Q3 2021 · Sep 30, 2020 $14.22M
Long Term Debt Q3 2021 · Sep 30, 2021 $18.4M
Long Term Debt Q3 2021 · Dec 31, 2020 $24.67M
Short Term Debt Q3 2021 · Sep 30, 2021 $2.92M
Short Term Debt Q3 2021 · Dec 31, 2020 $16.23M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $57.37M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $53.14M
Stockholders Equity Q3 2021 · Sep 30, 2021 $140.83M
Stockholders Equity Q3 2021 · Jun 30, 2021 $132.03M
Stockholders Equity Q3 2021 · Dec 31, 2020 $119.12M
Stockholders Equity Q3 2021 · Sep 30, 2020 $65.24M
Stockholders Equity Q3 2021 · Jun 30, 2020 $57.33M
Stockholders Equity Q3 2021 · Dec 31, 2019 $54.5M
Current Liabilities Q3 2021 · Sep 30, 2021 $52.53M
Current Liabilities Q3 2021 · Dec 31, 2020 $63.21M
Total Liabilities Q3 2021 · Sep 30, 2021 $75.91M
Total Liabilities Q3 2021 · Dec 31, 2020 $93.42M
Current Assets Q3 2021 · Sep 30, 2021 $133.43M
Current Assets Q3 2021 · Dec 31, 2020 $126.59M
Total Assets Q3 2021 · Sep 30, 2021 $216.74M
Total Assets Q3 2021 · Dec 31, 2020 $212.53M
Eps Diluted Q3 2021 · Sep 30, 2021 $0.03
Eps Diluted Q3 2021 · Sep 30, 2021 $0.08
Eps Diluted Q3 2021 · Sep 30, 2020 $0.03
Eps Diluted Q3 2021 · Sep 30, 2020 $0.03
Eps Basic Q3 2021 · Sep 30, 2021 $0.03
Eps Basic Q3 2021 · Sep 30, 2021 $0.08
Eps Basic Q3 2021 · Sep 30, 2020 $0.03
Eps Basic Q3 2021 · Sep 30, 2020 $0.03
Sga Expense Q3 2021 · Sep 30, 2021 $19.87M
Sga Expense Q3 2021 · Sep 30, 2021 $55.19M
Sga Expense Q3 2021 · Sep 30, 2020 $15.23M
Sga Expense Q3 2021 · Sep 30, 2020 $46.1M
Rd Expense Q3 2021 · Sep 30, 2021 $3.92M
Rd Expense Q3 2021 · Sep 30, 2021 $10.61M
Rd Expense Q3 2021 · Sep 30, 2020 $2.41M
Rd Expense Q3 2021 · Sep 30, 2020 $7.8M
Net Income Q3 2021 · Sep 30, 2021 $5.39M
Net Income Q3 2021 · Sep 30, 2021 $13.61M
Net Income Q3 2021 · Sep 30, 2020 $5M
Net Income Q3 2021 · Sep 30, 2020 $4.82M
Operating Income Q3 2021 · Sep 30, 2021 $7.97M
Operating Income Q3 2021 · Sep 30, 2021 $20.14M
Operating Income Q3 2021 · Sep 30, 2020 $5.85M
Operating Income Q3 2021 · Sep 30, 2020 $7.52M
Revenue Q3 2021 · Sep 30, 2021 $48.19M
Revenue Q3 2021 · Sep 30, 2021 $135.25M
Revenue Q3 2021 · Sep 30, 2020 $40M
Revenue Q3 2021 · Sep 30, 2020 $105.47M